Oxbow Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-104,749
| Closed | -$5.05M | – | 223 |
|
|
2024
Q4 | $5.05M | Buy |
104,749
+4,790
| +5% | +$231K | 0.59% | 46 |
|
|
2024
Q3 | $5.76M | Buy |
99,959
+233
| +0.2% | +$13.4K | 0.57% | 41 |
|
|
2024
Q2 | $4.84M | Buy |
99,726
+3,420
| +4% | +$166K | 0.57% | 48 |
|
|
2024
Q1 | $4.68M | Buy |
96,306
+2,012
| +2% | +$97.8K | 0.64% | 48 |
|
|
2023
Q4 | $4.69M | Buy |
+94,294
| New | +$4.69M | 0.71% | 38 |
|
|
2019
Q3 | – | Sell |
-36,294
| Closed | -$1.57M | – | 309 |
|
|
2019
Q2 | $1.57M | Buy |
36,294
+1,250
| +4% | +$54.1K | 0.19% | 115 |
|
|
2019
Q1 | $1.55M | Buy |
35,044
+885
| +3% | +$39.2K | 0.19% | 114 |
|
|
2018
Q4 | $1.48M | Sell |
34,159
-40,825
| -54% | -$1.77M | 0.2% | 106 |
|
|
2018
Q3 | $3.35M | Sell |
74,984
-4,446
| -6% | -$199K | 0.4% | 68 |
|
|
2018
Q2 | $3.18M | Sell |
79,430
-630
| -0.8% | -$25.2K | 0.4% | 71 |
|
|
2018
Q1 | $3.21M | Buy |
80,060
+4,705
| +6% | +$189K | 0.65% | 48 |
|
|
2017
Q4 | $3.24M | Buy |
75,355
+2,950
| +4% | +$127K | 0.61% | 49 |
|
|
2017
Q3 | $3.61M | Sell |
72,405
-7,535
| -9% | -$375K | 0.69% | 44 |
|
|
2017
Q2 | $3.83M | Sell |
79,940
-1,795
| -2% | -$86K | 0.68% | 51 |
|
|
2017
Q1 | $3.7M | Sell |
81,735
-970
| -1% | -$43.9K | 0.6% | 53 |
|
|
2016
Q4 | $3.35M | Sell |
82,705
-1,310
| -2% | -$53K | 0.42% | 67 |
|
|
2016
Q3 | $3.21M | Buy |
84,015
+220
| +0.3% | +$8.41K | 0.44% | 70 |
|
|
2016
Q2 | $3.51M | Buy |
+83,795
| New | +$3.51M | 0.5% | 61 |
|